Goldman Sachs’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-508,062
| Closed | -$19.5M | – | 5085 |
|
|
2023
Q2 | $19.5M | Buy |
508,062
+158,756
| +45% | +$6.1M | ﹤0.01% | 1573 |
|
|
2023
Q1 | $8.09M | Buy |
349,306
+137,130
| +65% | +$3.17M | ﹤0.01% | 2183 |
|
|
2022
Q4 | $5.56M | Sell |
212,176
-190,414
| -47% | -$4.99M | ﹤0.01% | 2538 |
|
|
2022
Q3 | $7.92M | Buy |
402,590
+168,861
| +72% | +$3.32M | ﹤0.01% | 2304 |
|
|
2022
Q2 | $4.09M | Sell |
233,729
-1,009
| -0.4% | -$17.6K | ﹤0.01% | 2832 |
|
|
2022
Q1 | $3.84M | Buy |
234,738
+16,512
| +8% | +$270K | ﹤0.01% | 3014 |
|
|
2021
Q4 | $3.56M | Buy |
218,226
+23,289
| +12% | +$380K | ﹤0.01% | 3069 |
|
|
2021
Q3 | $2.49M | Buy |
194,937
+41,407
| +27% | +$528K | ﹤0.01% | 3305 |
|
|
2021
Q2 | $2.17M | Buy |
153,530
+134,625
| +712% | +$1.9M | ﹤0.01% | 3450 |
|
|
2021
Q1 | $294K | Sell |
18,905
-1,893
| -9% | -$29.4K | ﹤0.01% | 4650 |
|
|
2020
Q4 | $330K | Buy |
20,798
+7,860
| +61% | +$125K | ﹤0.01% | 4040 |
|
|
2020
Q3 | $157K | Sell |
12,938
-34,125
| -73% | -$414K | ﹤0.01% | 4133 |
|
|
2020
Q2 | $544K | Buy |
47,063
+32,354
| +220% | +$374K | ﹤0.01% | 3562 |
|
|
2020
Q1 | $201K | Sell |
14,709
-140,275
| -91% | -$1.92M | ﹤0.01% | 3939 |
|
|
2019
Q4 | $914K | Buy |
154,984
+125,554
| +427% | +$740K | ﹤0.01% | 3376 |
|
|
2019
Q3 | $156K | Sell |
29,430
-42,513
| -59% | -$225K | ﹤0.01% | 3977 |
|
|
2019
Q2 | $554K | Buy |
71,943
+21,133
| +42% | +$163K | ﹤0.01% | 3483 |
|
|
2019
Q1 | $1.01M | Buy |
50,810
+1,520
| +3% | +$30.2K | ﹤0.01% | 3253 |
|
|
2018
Q4 | $651K | Buy |
49,290
+18,532
| +60% | +$245K | ﹤0.01% | 3318 |
|
|
2018
Q3 | $1.13M | Sell |
30,758
-6,471
| -17% | -$238K | ﹤0.01% | 3134 |
|
|
2018
Q2 | $1.3M | Sell |
37,229
-40,512
| -52% | -$1.42M | ﹤0.01% | 3070 |
|
|
2018
Q1 | $3.62M | Buy |
77,741
+18,940
| +32% | +$881K | ﹤0.01% | 2528 |
|
|
2017
Q4 | $2.21M | Buy |
58,801
+20,195
| +52% | +$757K | ﹤0.01% | 2780 |
|
|
2017
Q3 | $2.06M | Sell |
38,606
-5,609
| -13% | -$299K | ﹤0.01% | 2865 |
|
|
2017
Q2 | $2.52M | Sell |
44,215
-3,129
| -7% | -$178K | ﹤0.01% | 2672 |
|
|
2017
Q1 | $2.55M | Buy |
47,344
+36,347
| +331% | +$1.95M | ﹤0.01% | 2576 |
|
|
2016
Q4 | $627K | Buy |
10,997
+5,756
| +110% | +$328K | ﹤0.01% | 3329 |
|
|
2016
Q3 | $326K | Buy |
5,241
+565
| +12% | +$35.1K | ﹤0.01% | 3664 |
|
|
2016
Q2 | $264K | Sell |
4,676
-4,962
| -51% | -$280K | ﹤0.01% | 3701 |
|
|
2016
Q1 | $617K | Buy |
9,638
+2,338
| +32% | +$150K | ﹤0.01% | 3110 |
|
|
2015
Q4 | $1.03M | Buy |
+7,300
| New | +$1.03M | ﹤0.01% | 2882 |
|